Trilostane

An inhibitor of the 3β-HSDs: 3β-HSD1 and 3β-HSD2 (Kis = 0.10 and 1.60 μM, respectively); approved for use in reducing cortisol, aldosterone, and corticosterone levels in dogs diagnosed with Cushing’s syndrome; may potentially benefit the treatment of breast cancer in postmenopausal women
Read more
€0.00 (tax incl.)
Reference:
14164-50
Product Details
14164-50

Data sheet

Size
50 mg
CAS
13647-35-3
URL - Product
http://www.caymanchem.com/pdfs/14164.pdf

Menu

Settings